Industry News
Biota records small year-end loss
Biota’s long-running legal battle with GSK has taken its toll, with the company recording a $20 million loss for the year. [ + ]
Horses for courses for Bioeffectives
Bioeffectives show promise as effective treatment of equine gastric ulcers and as a replacement for antibiotics in poultry feed. [ + ]
No pain for Xenome
Synthetic venom peptide shows promise in trials [ + ]
Spine fusion for Mesoblast
Mesoblast's stem cells effective method for cervical spine fusion [ + ]
QRXPharma writes off
QRxPharma reports $36 million deficit [ + ]
Market in sight for Pharmaxis
Pharmaxis concludes Phase 3 trial of Bronchitol [ + ]
Happy as a pig
Imugene reports early PRRS vaccine trial results [ + ]
Good dose for Viralytics
Viralytics progresses through Phase 1 trial of Cavatak [ + ]
Anadis fights flu
Anadis shows proof-of-principle for spray-based 'flu fighter' [ + ]
US Pharmacopeia achieves ISO accreditation for Certified Reference Materials
The US Pharmacopeial Convention has achieved accreditation from ACLASS to the ISO Guide 34 for reference material producers as an internationally accredited producer of Certified Reference Materials.
[ + ]Investment boost for UniQuest start-up companies
Two companies that were established to develop discoveries from the Australian Institute for Bioengineering and Nanotechnology (AIBN) at UQ have received funding to boost their research priorities.
[ + ]Aldridge quits Peplin
Peplin appoints new CEO and president/CMO [ + ]
Patent no loss of MatrixView
MatrixView awarded European patent for data management technology [ + ]
$3 million for Chagas research
Murdoch University and Epichem get $3 million Chagas research boost [ + ]
Genentech rejects Roche bid
US biotech Genentech rejects $43.7 billion takeover deal [ + ]
